Jazz Pharmaceuticals Bets on Cannabis-based Medicines with US$7.2 B GW Pharmaceuticals Buy
By Neha Madhwani & Michelle Liu
Pharma Deals Review: Vol 2021 Issue 3 (Table of Contents)
Published: 31 Mar-2021
DOI: 10.3833/pdr.v2021.i3.2601 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In its largest M&A deal to date, Jazz Pharmaceuticals has agreed to acquire GW Pharmaceuticals to expand its neuroscience portfolio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS